Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity

Cancer Gene Therapy
W F ChengC-A Chen

Abstract

Alphavirus vectors have emerged as a promising strategy for the development of cancer vaccines and gene therapy applications. In this study, we used the replication-defective vaccine vector SIN replicon particles from a new packaging cell line (PCL) to develop SIN replicon particles encoding calreticulin (CRT) linked to a model tumor antigen, human papillomavirus type 16 (HPV16) E7 protein. The linkage of CRT to E7 in SIN replicon particles resulted in a significant increase in E7-specific CD8(+) T-cell precursors and a strong antitumor effect against E7-expressing tumors in vaccinated mice. SINrep5-CRT/E7 replicon particles enhanced presentation of E7 through the major histocompatibility complex (MHC) class I pathway by infecting dendritic cells (DCs) directly and pulsing DCs with lysates of cells infected by SINrep5-CRT/E7 replicons. Vaccination of immunocompromised (BALB/c nu/nu) mice with SINrep5-CRT/E7 replicon particles also generated significant reduction of lung tumor nodules, suggesting that antiangiogenesis may contribute to the antitumor effect of SINrep5-CRT/E7 replicon particles. Furthermore, SINrep5-CRT/E7 replicon particles generated long-term in vivo tumor protection effects and antigen-specific memory immunitie...Continue Reading

References

Jun 15, 1994·Molecular and Cellular Biochemistry·P D NashM Michalak
Dec 1, 1993·British Journal of Cancer·I M HarwerthN E Hynes
Sep 1, 1994·Microbiological Reviews·J H Strauss, E G Strauss
Nov 1, 1993·Journal of Virology·P J BredenbeekS Schlesinger
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·I FrolovC M Rice
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·J M PoloT W Dubensky
Jul 8, 1999·Nature Medicine·H YingN P Restifo
Oct 6, 1999·Current Opinion in Biotechnology·S Schlesinger, T W Dubensky
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·W F ChengT C Wu
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil L Berinstein
Jul 9, 2004·Biochimica Et Biophysica Acta·Said DermimePeter L Stern
Jan 12, 2005·Breast Cancer Research : BCR·Xiaoyan WangLawrence B Lachman

❮ Previous
Next ❯

Citations

Nov 13, 2008·Expert Reviews in Molecular Medicine·Gregory J AtkinsBrian J Sheahan
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Aug 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jennifer E PhillipsAndrés J García
Jun 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Marc GitzingerMartin Fussenegger
Mar 14, 2007·Stem Cells and Development·Neeraj Kumar SatijaR P Tripathi
May 28, 2010·Tissue Engineering. Part a·Yash M KolambkarRobert E Guldberg
Apr 24, 2010·Tissue Engineering. Part a·Abigail M WojtowiczAndrés J García
Dec 22, 2011·Nucleic Acids Research·Marc GitzingerMartin Fussenegger
Nov 27, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Leslie I GoldJoanne E Murphy-Ullrich
Apr 12, 2007·Annual Review of Biomedical Engineering·Charles A GersbachAndrés J García
Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jun-Han SuT-C Wu
Oct 2, 2014·Expert Review of Vaccines·Karl Ljungberg, Peter Liljeström
Jan 1, 2014·Vaccines·Hadeel KhalloufAngelika B Riemer
Jun 18, 2014·Viruses·Kenneth Lundstrom
Aug 10, 2010·Virus Research·Jose I QuetglasCristian Smerdou
Mar 28, 2008·Immunological Reviews·Chien-Fu HungRichard Roden
Aug 27, 2015·Virus Research·Kenneth Lundstrom
Feb 2, 2012·Journal of Experimental & Clinical Cancer Research : CR·Xin-Li LiuPing Ma
Nov 10, 2016·Vaccines·Kenneth Lundstrom
Apr 24, 2014·Therapeutic Advances in Vaccines·Emeline Ragonnaud, Peter Holst
Jan 13, 2009·The Biochemical Journal·Marek MichalakMichal Opas

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.